VLA4-Targeted nanoparticles hijack cell adhesion-mediated drug resistance to target refractory myeloma cells and prolong survival

Francesca Fontana, Michael J. Scott, John S. Allen, Xiaoxia Yang, Grace Cui, Dipanjan Pan, Noriko Yanaba, Mark A. Fiala, Julie O'Neal, Anne H. Schmieder-Atteberry, Julie Ritchey, Michael Rettig, Kathleen Simons, Steven Fletcher, Ravi Vij, John F. DiPersio, Gregory M. Lanza